Publisher Correction: Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab

Leukemia. 2022 Jan;36(1):297. doi: 10.1038/s41375-021-01355-6.
No abstract available

Publication types

  • Published Erratum